13F-HR filed by Commodore Capital LP
Commodore Capital LP filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 30 holding rows worth $855,509,177.
- Accession
- 0001831942-23-000011
- Filer
- CIK 1831942
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 30 entries on the cover page, a total value of $855,509,177 stated on the cover page (in dollars after the unit check, H1), rows summing to $855,509,177 with VALUE read as dollars as filed, 13F file number 028-20976. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MERUS N V | N5749R100 | COM | 4,428,072 | $104,413,938 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 5,450,000 | $74,719,500 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,845,000 | $63,025,200 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 1,100,000 | $56,078,000 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 5,566,026 | $54,268,754 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 2,075,000 | $47,569,375 | dollars as filed | |
| AMBRX BIOPHARMA, INC. SPONSORED ADR | 02290A102 | COM | 3,518,556 | $40,463,394 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 2,901,816 | $39,638,807 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 2,525,753 | $38,441,961 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 1,000,000 | $38,390,000 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 828,778 | $38,098,925 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 2,200,000 | $33,748,000 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 565,000 | $28,577,700 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 887,500 | $26,190,125 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 775,000 | $20,909,500 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 706,665 | $19,447,421 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 1,694,141 | $15,484,449 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 1,325,000 | $15,171,250 | dollars as filed | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 10,000,000 | $15,000,000 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 500,000 | $14,870,000 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 957,509 | $13,903,031 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 1,400,000 | $12,768,000 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 1,700,000 | $10,863,000 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 739,661 | $9,075,640 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 1,575,000 | $8,253,000 | dollars as filed | |
| RAYZEBIO INC | 75525N107 | COM | 288,911 | $6,413,824 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 250,000 | $5,325,000 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 2,244,378 | $2,850,360 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 116,324 | $1,424,969 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 92,687 | $126,054 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001831942-23-000011 | this filing | 2023-11-14 | acceptance time not in the bulk data set |